Sergio Rigau

BD Biosciences, Systems & Reagents, Inc. provides tools and solutions to research and clinical laboratories in basic research, drug discovery, development, biopharmaceutical production and disease management. The company was founded on May 9, 1991 and is headquartered in San Jose, CA.

The Fertility Partnership Ltd. provides fertility services. Its services include surgical sperm retrieval, time lapse imaging, embryoglue and assisted hatching. The company was founded by David Elan Simckes in 1985 and is headquartered in Oxford, the United Kingdom.

Linden Manager LLC (Linden Capital Partners) is a private equity firm founded in 2004 by Anthony B Davis and Brain C Miller. The firm is headquartered in Chicago, Illinois.

Atlantis Healthcare Group Ltd. develops and distributes software related to patient support services. It engages in designing, implementing and operating patient support and adherence programs for the pharmaceutical and other health related industries. The firm’s solutions include self-management behaviors, understanding behavior change, solutions for the patient journey, behavior change techniques and personalized program. The company is headquartered in Auckland, New Zealand.

Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

San José State University Research Foundation is a non-profit organization that is focused on the provision of services for the welfare of the university through assistance in research, education, and community service. The foundation was founded in 1932 and is headquartered in San Jose, CA.

Biobeats Group Ltd. engages in the design and development of mobile software applications. It offers BioBase app. The company was founded by Nadeem Iqbal Kassam, David Plans and Davide Morelli in 2013 and is headquartered in London, the United Kingdom.

Continum Group Ltd. engages in the innovative business driven information technology and communications products and solutions. It operates in the followng divisions: Continum 42, Continum, Xempower, and 4 Business Calls. The Continum 42 handles the research and development facilities. The Continum refers to the innovative IT and communication solutions. The Xempower manages hosted applications and IT platforms. The 4 Business Calls manages hosted telephony solutions. The company is headquartered in Bury, the United Kingdom.

Autoclenz Holdings Ltd. is based in Swadlincote, UK, and has subsidiaries in the UK. Autoclenz Holdings Ltd. operates as a holding British company whose subsidiaries provide motor vehicle cleaning services. Autoclenz Holdings is a holding company founded in 2015.

Boldwood Ltd. invests in companies that have a stake in public relations services. The private company is based in London, UK.

Part of Boldwood Ltd., Hansard Corporate Ltd. is a British company that provides public relations services. The company is based in London, UK.

Autoclenz Ltd. provides outsourced car valeting and vehicle preparation services. Its services include valeting, cosmetic repairs, customer experience, delivery and collection, imaging, premises cleaning and prestige valeting. The company was founded in 1969 and is headquartered in Swadlincote, the United Kingdom.

The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009.

Penrhos Bio Ltd. is a British bioscience company that specializes in controlling the formation of harmful biofilms. The company is based in London, UK. The company has developed a novel and sustainable solution to biofilms by learning from the natural biology of the oceans. Penrhos Bio is working with potential license partners across a range of industries to develop lactam solutions to sector-specific biofilm challenges. The company was founded in 2019. Richard Andrew Hammond has been the CEO of the company since 2022.

Predictimmune Ltd. develops tools for guiding treatment options in immune-mediated inflammatory diseases. It offers PredictSURE IBD is a biomarker test, combined with a sophisticated, proprietary algorithm that will tell the likely course of newly diagnosed patients’ IBD, differentiating between an aggressive or milder form of the disease. The company was founded in May 2017 and is headquartered in Cambridge, the United Kingdom.

NovaBiotics Ltd. operates as a clinical-stage biotechnology firm. It designs and develops antifungal and antibacterial therapeutics for medically unmet fungal, bacterial, and polymicrobial conditions. It offers clinical and preclinical product candidates to treat clinically challenging infections that include NP213 (Novexatin) phase IIb-ready potent topical treatment for fungal nail infections (onychomycosis); NM001 (Lynovex), a dual antibacterial-mucolytic orphan drug candidate in phase IIa clinical evaluation for cystic fibrosis; NP339 (Novamycin), an antifungal peptide agent against Candida spp and other clinically relevant yeasts/moulds; and NP432 (Novarifyn), a peptide antibacterial candidate for multi-drug resistant gram-negative and gram-positive infections. The company was founded by Deborah A. O?Neil in August 2004 and is headquartered in Aberdeen, the United Kingdom.

Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France.

Ariana Pharmaceuticals SA provides pharmaceutical, clinical and data technology. It offers analytics for multi-paramedic data in identifying patient responders to reduce clinical and drug development risk. The firm also develops biomarker signatures to develop processes in anawlyzing multi-paramedic data. The company was founded by Mohammad Afshar in 2003 and is headquartered in Paris, France.